Advanced Therapy Medicinal Products for Age-Related Macular Degeneration; Scaffold Fabrication and Delivery Methods
Retinal degenerative diseases such as age-related macular degeneration (AMD) represent a leading cause of blindness, resulting in permanent damage to retinal cells that are essential for maintaining normal vision. Around 12% of people over the age of 65 have some form of retinal degenerative disease...
Saved in:
Main Authors: | Hanieh Khalili (Author), Hamid Heidari Kashkoli (Author), David Edward Weyland (Author), Sama Pirkalkhoran (Author), Wiktoria Roksana Grabowska (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent Advances and New Perspectives in Managing Macular Degeneration
Published: (2022) -
Recent advances of exosomes in age-related macular degeneration
by: Feng Gu, et al.
Published: (2023) -
THE EFFICACY AND SAFETY PROFILE OF ADVANCED THERAPY MEDICINAL PRODUCTS IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
by: R. N. Alyautdin, et al.
Published: (2022) -
Age Related Macular Degeneration The Recent Advances in Basic Research and Clinical Care
Published: (2012) -
Nanotechnology for Age-Related Macular Degeneration
by: Bo Yang, et al.
Published: (2021)